Evotec CEO resigns
This article was originally published in Scrip
Jörn Aldag is to resign as president and CEO of Evotecat the end of the year. The company will be co-led by Dr Mario Polywka, currently chief operating officer, and Dr Klaus Maleck, chief financial officer, until a permanent successor is found. Mr Aldag has been with Evotec for 11 years and has overseen the company's transformation from a technology provider to a CNS-focused biopharmaceutical company.